Department of Pharmacology, University of Illinois-Chicago College of Medicine, Chicago, IL, 60612, USA.
Department of Hematology, Zhongnan Hospital of Wuhan University, 430071, Wuhan, Hubei, P.R. China.
Exp Mol Med. 2020 Mar;52(3):390-399. doi: 10.1038/s12276-020-0401-5. Epub 2020 Mar 18.
Protein disulfide isomerase (PDI) participates in the pathogenesis of numerous diseases. Increasing evidence indicates that intravascular cell-derived PDI plays an important role in the initiation and progression of cardiovascular diseases, including thrombosis and vascular inflammation. Recent studies with PDI conditional knockout mice have advanced our understanding of the function of cell-specific PDI in disease processes. Furthermore, the identification and development of novel small-molecule PDI inhibitors has led into a new era of PDI research that transitioned from the bench to bedside. In this review, we will discuss recent findings on the regulatory role of PDI in cardiovascular disease.
蛋白质二硫键异构酶(PDI)参与了许多疾病的发病机制。越来越多的证据表明,血管细胞来源的 PDI 在血栓形成和血管炎症等心血管疾病的发生和发展中起着重要作用。使用 PDI 条件性敲除小鼠进行的最近研究,加深了我们对细胞特异性 PDI 在疾病过程中的功能的理解。此外,新型小分子 PDI 抑制剂的鉴定和开发,将 PDI 研究从实验室带入了临床实践的新时代。在这篇综述中,我们将讨论 PDI 在心血管疾病中的调节作用的最新发现。